Clinical study of chlamydia pneumoniae infection in patients with coronary heart disease

BackgroundThis study aims to investigate the chlamydia pneumoniae infection (PC) in patients with coronary heart disease.MethodsA total of 92 patients with coronary heart disease, who were treated with percutaneous coronary intervention (PCI), were selected as the case group. In addition, 50 healthy people were enrolled as the control group. The incidences of CP infection and serum Chlamydia pneumoniae IgA antibody (CP-IgA), high sensitive C-reactive protein (hs-CRP), and interleukin-6 (IL-6) were compared in these two groups. The classification of coronary artery lesion, the incidence of perioperative cardiovascular events, and adverse prognosis events within six months after procedure were compared.ResultsThe incidence of CP infection in the case group was higher (42.4% vs. 0%, P<0.05). Furthermore, 17 patients were at grade I, 39 patients were at grade II, and 36 patients were at grade III. The incidences for these three kinds of patients were 17.6, 30.8, and 66.7%. The incidence of CP infection at grade III was higher than that of grade I or II (P<0.05). Serum CP-IgA, hs-CRP and IL-6 levels increased with the severity of the coronary artery disease (P<0.05), and the serum hs-CRP and IL-6 levels of patients with perioperative cardiovascular events were higher (P<0.05). Moreover, the serum CP-IgA levels of the patients with adverse prognosis events were also higher (P<0.05).ConclusionsPatients with coronary heart disease have a high CP infection rate. The degree of infection is relevant to the severity of the coronary artery lesions and postoperative prognosis of patients, suggesting that CP infection may be an important factor affecting the incidence and prognosis of coronary heart disease.